Health Care & Life Sciences » Biotechnology | China BCT Pharmacy Group Inc.

China BCT Pharmacy Group Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2008
2009
2010
2011
2012
Cash & Short Term Investments
2,493.20
14,459.90
21,492.00
32,531.60
30,590.70
Total Accounts Receivable
25,927.50
40,846.40
72,960.80
119,723.00
146,990.20
Inventories
6,425.80
8,745.50
10,776.90
14,183.10
13,602.10
Other Current Assets
1,019.50
1,425.80
3,027.60
5,649.10
8,342.00
Total Current Assets
35,865.90
65,477.60
108,257.20
172,086.80
199,524.90
Net Property, Plant & Equipment
12,413.30
12,171.70
14,605.90
18,097.10
22,513.90
Total Investments and Advances
299.30
-
-
31.40
31.70
Intangible Assets
16,561.20
14,747.80
14,563.90
14,629.20
14,264.30
Other Assets
-
-
3,482.20
7,070.40
7,726.50
Total Assets
65,814.30
93,060.80
141,539.00
212,582.40
244,972.60
ST Debt & Current Portion LT Debt
14,120.50
10,193.90
9,251.40
9,405.30
26,575.20
Accounts Payable
15,007.30
19,159.20
38,167.10
44,394.40
39,723.00
Income Tax Payable
954.70
562.60
2,564.40
2,726.90
834.60
Other Current Liabilities
4,767.90
5,933.50
5,029.60
5,574.70
6,351.10
Total Current Liabilities
34,850.40
35,849.20
55,012.40
62,101.20
73,483.80
Long-Term Debt
2,200.50
3,632.00
1,941.60
206.80
113.40
Provision for Risks & Charges
-
-
213.80
177.40
162.40
Deferred Taxes
674.60
663.70
629.80
667.50
911.20
Other Liabilities
180.40
201.30
1,273.20
191.00
-
Total Liabilities
37,231.30
39,682.50
58,441.00
62,676.30
73,759.70
Common Equity (Total)
28,583.10
53,378.30
83,098.10
116,520.20
134,265.20
Total Shareholders' Equity
28,583.10
53,378.30
83,098.10
149,906.10
171,212.90
Total Equity
28,583.10
53,378.30
83,098.10
149,906.10
171,212.90
Liabilities & Shareholders' Equity
65,814.30
93,060.80
141,539.00
212,582.40
244,972.60
Preferred Stock (Carrying Value)
-
-
-
33,385.90
36,947.70

About China BCT Pharmacy Group

View Profile
Address
No. 102 Chengzhan Road
Liuzhou Guangzi Zhuang 545007
China
Employees -
Website -
Updated 07/08/2019
China BCT Pharmacy Group, Inc. engages in the pharmaceutical distribution, retail pharmacy and manufacture of pharmaceuticals through its wholly-owned subsidiaries; Guangxi Liuzhou Baicaotang Medicine Ltd. and Hefeng Pharmaceutical Co. Ltd. The company's operates through three business segments include Pharmaceutical Distribution, Retail Pharmacy and Manufacturing. The Pharmaceutical Distribution segment provides pharmaceutical and healthcare products, including branded, generic prescription medicines and over-the counter medicines. The Retail Pharmacy segment provides offers professional pharmaceutical services and supplies a variety of medicines such as prescription medicines, over-the-counter medicines, Chinese herbal medicine, roughly processed Chinese herbal medicine and family planning products.